Literature DB >> 32725477

Bipolar-current needle-knife with a water jet function (Jet B-knife) shortens the procedure time of endoscopic submucosal dissection for colorectal tumors.

Katsushi Hiramatsu1, Tatsushi Naito1, Yu Akazawa1, Yasushi Saito1, Takuto Nosaka1, Kazuto Takahashi1, Kazuya Ofuji1, Hidetaka Matsuda1, Masahiro Ohtani1, Mitsuru Matsuda2, Akito Sakai2, Yasunari Nakamoto3.   

Abstract

BACKGROUND: Endoscopic submucosal dissection (ESD) is a technically difficult and time-consuming procedure for the treatment of large colorectal tumors. In Japan, the ball-tip bipolar-current needle-knife (BB-knife) has been used in ESD as a safe device that minimizes the damage to deeper tissues of colorectal neoplasms. In May 2012, a BB-knife combined with a water jet function (Jet B-knife) was newly developed.
METHODS: This retrospective study was aimed at examining the effectiveness and safety of the Jet B-knife. The BB-knife was used in 276 lesions (BB-knife group), while the Jet B-knife was used in 245 lesions (Jet B-knife group). We evaluated tumor characteristics and the results of the ESD procedures, including the size of the resected tumor, histological diagnosis, time required for resection, frequency of using other electrical devices, en bloc resection rate, and incidence rate of associated complications. Then, the data obtained were compared between the two groups.
RESULTS: The histological evaluation of the resected tumors revealed that the incidence of cancer was not significantly different between the two groups. The median time required for resection was 103 min (45-255) in the BB-knife group and 51 min (28-210) in the Jet B-knife group. The difference was statistically significant (p < 0.05). Furthermore, the median tumor diameters were 23.1 mm (18-50) and 26.2 mm (20-60) in the BB-knife and Jet B-knife groups, respectively, demonstrating a statistically significant difference (p < 0.05). Multivariate logistic regression analysis revealed that short resection time (p < 0.001) and reduced use of hemostatic devices (p < 0.01) were independent favorable features of Jet B-knife. The en bloc resection rate and the perforation rate were not statistically significant between the two groups.
CONCLUSIONS: Use of the Jet B-knife may contribute to the development of a time-saving, cost-effective, and safe procedure for ESD of colorectal tumors.

Entities:  

Keywords:  Ball-tip bipolar-current needle-knife; Colorectal tumor; Endoscopic submucosal dissection; Spray coagulation

Mesh:

Substances:

Year:  2020        PMID: 32725477     DOI: 10.1007/s00464-020-07832-w

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  1 in total

1.  Usefulness of IT knife nano for endoscopic submucosal dissection of large colo-rectal lesions.

Authors:  T Suzuki; T Hara; Y Kitagawa; T Yamaguchi
Journal:  Acta Gastroenterol Belg       Date:  2016 Apr-Jun       Impact factor: 1.316

  1 in total
  3 in total

1.  A Novelly Developed Bipolar Needle Knife Can Be an Alternative Device Choice for Endoscopic Submucosal Dissection (With Video).

Authors:  Shengsen Chen; Danping Zhou; Jiangping Yu; Rongwei Ruan; Yuanshun Liu; Yandong Li; Qiwen Shen; Shi Wang
Journal:  Front Med (Lausanne)       Date:  2022-05-13

2.  Comparisons of outcomes between ProKnife injection endoscopic submucosal dissection and conventional endoscopic submucosal dissection for large gastric lesions in ex vivo porcine model study: A randomized controlled trial.

Authors:  Mitsuru Esaki; Eikichi Ihara; Misato Esaki; Kei Nishioka; Yusuke Kimura; Yoshitaka Hata; Hirotaka Tsuru; Masafumi Wada; Yosuke Minoda; Xiaopeng Bai; Yoshihisa Shoguchi; Takayuki Nasu; Shuzaburo Nagatomo; Kazumasa Muta; Haruei Ogino; Yoshihiro Ogawa
Journal:  DEN open       Date:  2022-01-26

3.  Effect of Acupotomy Combined with Electroacupuncture Therapy on Finger Mobility and Pain Relief in Patients with Carpal Tunnel Syndrome.

Authors:  Jianfei Li; Yinqiao Kou; Suzhao Zhang; Kaibing Wang
Journal:  Comput Math Methods Med       Date:  2022-07-14       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.